↓ Skip to main content

Melatonin, Neuroprotective Agents and Antidepressant Therapy

Overview of attention for book
Cover of 'Melatonin, Neuroprotective Agents and Antidepressant Therapy'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 History of Pineal Gland as Neuroendocrine Organ and the Discovery of Melatonin
  3. Altmetric Badge
    Chapter 2 Bibliometric Study of Scientific Research on Melatonin During the Last 25 Years
  4. Altmetric Badge
    Chapter 3 Neuroimaging of the Pineal Gland: Focus on Primary Insomnia
  5. Altmetric Badge
    Chapter 4 Melatonin: Basic and Clinical Aspects
  6. Altmetric Badge
    Chapter 5 Melatonin and Melatonin Receptors in Neuroprotection
  7. Altmetric Badge
    Chapter 6 Melatonin Supplementation in Neurodegenerative Diseases: Current Status
  8. Altmetric Badge
    Chapter 7 Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration
  9. Altmetric Badge
    Chapter 8 Melatonin, a Neuroprotective Agent: Relevance for Stress-Induced Neuropsychiatric Disorders
  10. Altmetric Badge
    Chapter 9 Melatonin, Sleep, Circadian Rhythm, and Mood Disorders
  11. Altmetric Badge
    Chapter 10 Melatonin Induces Antidepressant-Like Behavior by Promotion of Adult Hippocampal Neurogenesis
  12. Altmetric Badge
    Chapter 11 Association Between Melatonin and Neuroimmune Diseases
  13. Altmetric Badge
    Chapter 12 Melatonin in Clinical Status of Patients with Fibromyalgia Syndrome
  14. Altmetric Badge
    Chapter 13 Melatonin’s Beneficial Effects in Hepatic Injury
  15. Altmetric Badge
    Chapter 14 Melatonin as a Novel Therapeutic Agent Against Chemical Warfare Agents
  16. Altmetric Badge
    Chapter 15 New Galenic Formulations of Melatonin
  17. Altmetric Badge
    Chapter 16 Melatonergic Drug Ramelteon in Neurotherapeutics
  18. Altmetric Badge
    Chapter 17 Melatonergic Antidepressant Agomelatine and Its Efficacy in Depressive Disorders
  19. Altmetric Badge
    Chapter 18 Agomelatine, Melatonin and Depression
  20. Altmetric Badge
    Chapter 19 Neuropsychological Models of Depression
  21. Altmetric Badge
    Chapter 20 Chronobiology of Mood Disorders
  22. Altmetric Badge
    Chapter 21 Bipolar Disorders and Biological Rhythms
  23. Altmetric Badge
    Chapter 22 Circadian Clock Genes and Mood Disorders
  24. Altmetric Badge
    Chapter 23 Understanding the Biologically Adaptive Side of Mood Disorders: A Focus on Affective Temperaments
  25. Altmetric Badge
    Chapter 24 Sleep Abnormalities as a Diagnostic Tool for Major Depressive Disorder
  26. Altmetric Badge
    Chapter 25 Depression: Correlations with Thyroid Hormones in Major Depressive Disorder
  27. Altmetric Badge
    Chapter 26 History of the Discovery of Antidepressant Drugs
  28. Altmetric Badge
    Chapter 27 Neurocognitive Deficit in Bipolar Disorders
  29. Altmetric Badge
    Chapter 28 Combination Strategies in Treatment-Resistant Depression
  30. Altmetric Badge
    Chapter 29 Antidepressant Drugs in Elderly
  31. Altmetric Badge
    Chapter 30 Antidepressant Efficacy of Escitalopram in Major Depressive Disorder
  32. Altmetric Badge
    Chapter 31 Antidepressant Medications and Suicide Risk: What Was the Impact of FDA Warning?
  33. Altmetric Badge
    Chapter 32 Neurobiology and Pharmacological Prevention of Suicide in Mood Disorders
  34. Altmetric Badge
    Chapter 33 Antidepressant and Anticonvulsant Drugs as Adjuvant Analgesics in Chronic Pain
  35. Altmetric Badge
    Chapter 34 Genetic Polymorphisms of Cytochrome P450 and Antidepressants
  36. Altmetric Badge
    Chapter 35 Pharmacogenomics of Antidepressant Drugs
  37. Altmetric Badge
    Chapter 36 Antidepressants Modulate Microglia Beyond the Neurotransmitters Doctrine of Mood Disorders
  38. Altmetric Badge
    Chapter 37 Brain-Derived Neurotrophic Factor (BDNF): TrkB Signaling in Depression – Biomarker and Novel Therapeutic Target
  39. Altmetric Badge
    Chapter 38 Targeting Opioid Receptors for Innovative Antidepressant Therapies: Rediscovering the Opioid Cure
  40. Altmetric Badge
    Chapter 39 Prolactin and Somatostatin Responses to Antidepressant Therapy
  41. Altmetric Badge
    Chapter 40 The Role of Vasopressin in Anxiety and Depression
  42. Altmetric Badge
    Chapter 41 Ketamine: The Glutamatergic Antidepressant and Its Efficacy
  43. Altmetric Badge
    Chapter 42 Acetylcholinergic Nicotinic Receptors as Pharmacological Targets for Cognitive Enhancement: Emerging Evidence from Psychosis Populations
  44. Altmetric Badge
    Chapter 43 The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models
  45. Altmetric Badge
    Chapter 44 Corticotropin-Releasing Factor Receptors as a Potential Target in the Developments of Antidepressant Drugs
  46. Altmetric Badge
    Chapter 45 Nitric Oxide Signaling in Depression and Antidepressant Action
  47. Altmetric Badge
    Chapter 46 The Role of Arrestins in the Neuroprotective Effects of Antidepressant Drugs
  48. Altmetric Badge
    Chapter 47 Antidepressant Drugs and Phosphodiesterases
  49. Altmetric Badge
    Chapter 48 Effects of Methylphenidate and Atomoxetine on Development of the Brain
  50. Altmetric Badge
    Chapter 49 S-Adenosyl-L-Methionine for Major Depressive Disorder
  51. Altmetric Badge
    Chapter 50 The Role of Antiepileptic Drugs in Bipolar Depression
  52. Altmetric Badge
    Chapter 51 Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
11 X users
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Melatonin, Neuroprotective Agents and Antidepressant Therapy
Published by
Springer India, January 2016
DOI 10.1007/978-81-322-2803-5
ISBNs
978-8-13-222801-1, 978-8-13-222803-5
Editors

Francisco López-Muñoz, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, Takahiro A. Kato

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Student > Master 6 12%
Student > Bachelor 5 10%
Student > Doctoral Student 4 8%
Researcher 4 8%
Other 11 22%
Unknown 15 29%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 6 12%
Medicine and Dentistry 6 12%
Neuroscience 6 12%
Agricultural and Biological Sciences 4 8%
Biochemistry, Genetics and Molecular Biology 4 8%
Other 9 18%
Unknown 16 31%